Yahoo Finance • 2 days ago
NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting fr... Full story
Yahoo Finance • 6 days ago
What Happened? A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations. The pharmaceutical and b... Full story
Yahoo Finance • 7 days ago
LOS ANGELES, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ: TNDM) in... Full story
Yahoo Finance • 8 days ago
LOS ANGELES, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ: TNDM) on behalf of investors concerning the Company’s possibl... Full story
Yahoo Finance • 9 days ago
SAN DIEGO, September 29, 2025--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ automated insulin deli... Full story
Yahoo Finance • 2 months ago
What Happened? A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer Price Index (CPI) report,... Full story
Yahoo Finance • 2 months ago
[Wall Street New York stock exchange stock market] alexsl Tandem Diabetes Care (NASDAQ:TNDM [https://seekingalpha.com/symbol/TNDM]) traded higher on Tuesday after Citi upgraded the insulin pump maker to Neutral from Sell, citing a shift i... Full story
Yahoo Finance • 2 months ago
Dublin, Aug. 11, 2025 (GLOBE NEWSWIRE) -- The "Tandem Diabetes Care Inc (TNDM) - Product Pipeline Analysis, 2025 Update" has been added to ResearchAndMarkets.com's offering. Tandem Diabetes Care Inc, a leading provider in the realm of... Full story
Yahoo Finance • 2 months ago
Investing.com - Piper Sandler downgraded Tandem Diabetes Care (NASDAQ:TNDM) from Overweight to Neutral on Thursday, while significantly reducing its price target to $14.00 from $30.00. The stock, currently trading at $14.39, has fallen ove... Full story
Yahoo Finance • 2 months ago
Tandem Diabetes Care Inc (NASDAQ:TNDM [https://www.chartmill.com/stock/quote/TNDM]) reported mixed second-quarter 2025 results, with revenue slightly below analyst expectations and a wider-than-anticipated loss per share. The company also... Full story
Yahoo Finance • 3 months ago
Tandem Diabetes Care (NASDAQ:TNDM) Inc’s stock has reached a new 52-week low, trading at 14.86 USD, down significantly from its 52-week high of 47.60 USD. This milestone comes amidst a challenging year for the company, with InvestingPro da... Full story
Yahoo Finance • 3 months ago
Investing.com - Piper Sandler has reiterated an Overweight rating and $150.00 price target on Abbott Labs (NYSE:ABT), currently trading near its 52-week high at $131.60, ahead of the company’s second-quarter earnings report expected on Jul... Full story
Yahoo Finance • 3 months ago
What Happened? A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned negative after the White... Full story
Yahoo Finance • 3 months ago
The S&P 500 Index ($SPX) (SPY) today is up +0.66%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.64%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.83%. September E-mini S&P futures (ESU25) are up +0.56%, and September E-mini N... Full story
Yahoo Finance • 3 months ago
Investing.com -- Citi analysts have taken action on two U.S. MedTech names, upgrading Haemonetics (NYSE:HAE) to Buy from Neutral, while downgrading Tandem Diabetes Care (NASDAQ:TNDM) to Sell/High Risk from Neutral/High Risk, citing divergi... Full story
Yahoo Finance • 3 months ago
Investing.com -- Tandem Diabetes Care (NASDAQ:TNDM) stock fell 5% Wednesday morning after Citi downgraded the medical device maker to Sell from Neutral, citing intensifying competitive pressures. Analyst Joanne Wuensch slashed the price t... Full story
Yahoo Finance • 3 months ago
Medtronic PLC (NYSE:MDT), a leading global medical technology company with a market capitalization of $113.25 billion, has been navigating a complex landscape of opportunities and challenges in recent months. According to InvestingPro dat... Full story
Yahoo Finance • 3 months ago
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the R... Full story
Yahoo Finance • 3 months ago
Shares of Dexcom, Tandem Diabetes and Insulet skidded Tuesday on a proposal that would cut Medicare reimbursements for wearable diabetes tech. Continue Reading View Comments... Full story
Yahoo Finance • 3 months ago
Yahoo Finance anchor Brad Smith examines some of the top headlines on Wall Street as part of today's Market Minute. Apple (AAPL) is reportedly considering using an external artificial intelligence (AI) language learning model (LLM) for Si... Full story